AXIM BIOTECHNOLOGIES, INC. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c2da5403-3b9a-495c-b738-712c2aa793a2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-2.8M | 2023-01-01 – 2023-12-31 | evidence 0001096906-24-000864 |
| FY 2022 | $-710.6k | 2022-04-01 – 2023-03-31 | evidence 0001096906-24-001202 |
| FY 2021 | $-14.0M | 2021-01-01 – 2021-12-31 | evidence 0001096906-22-000902 |
| FY 2020 | $-4.9M | 2020-01-01 – 2020-12-31 | evidence 0001078782-21-000395 |
| FY 2019 | $-3.1M | 2019-01-01 – 2019-12-31 | evidence 0001078782-21-000395 |
| FY 2018 | $-5.0M | 2018-01-01 – 2018-12-31 | evidence 0001078782-19-000304 |
| FY 2017 | $-3.1M | 2017-01-01 – 2017-12-31 | evidence 0001078782-18-000306 |
| FY 2016 | $-3.8M | 2016-01-01 – 2016-12-31 | evidence 0001078782-17-000517 |
| FY 2015 | $-10.0M | 2015-01-01 – 2015-12-31 | evidence 0001078782-17-000517 |
| FY 2014 | $-505.7k | 2014-01-01 – 2014-12-31 | evidence 0001387308-16-000190 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AXIM BIOTECHNOLOGIES, INC. — all facts · Revenue · Net Income